Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07024342 · ClinicalTrials.gov registry record · NA
Optimizing Prosthetic Prescription to Mitigate the Effects of Perspiration
A NA study of Amputation and Prosthesis User, sponsored by VA Puget Sound Health Care System.
- Active
- Registry status
- NA
- Development phase
- 180
- Enrollment target
- 1
- Study location
NCT07024342: Active NA study of Amputation and Prosthesis User, sponsored by VA Puget Sound Health Care System.
NCT07024342 is a NA study of Amputation and Prosthesis User that is active but no longer recruiting, run by VA Puget Sound Health Care System. The registered enrollment target is 180 participants, above the 130-participant average among 65 other Amputation trials with a reported enrollment target (38% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07024342, a NA study of Amputation and Prosthesis User, is active but no longer recruiting, sponsored by VA Puget Sound Health Care System.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 180 participants
- Enrollment target
- 1
- Study location
Study Summary
The specific aim of this research is to compare three clinically available liners, each intended to address problems of residual limb perspiration, with the as-prescribed liner of lower limb prosthesis user and determine their effect on stability, suspension, and comfort.
Primary Outcome
The Comprehensive Lower-limb Amputee Socket Survey (CLASS) is a self-report instrument that measures prosthesis stability, suspension, comfort, and appearance with very good internal consistency. The stability score measures how stable and balanced a person feels in their socket when they sit, stand, walk, and ascend or descend stairs.
Conditions Studied
Interventions
- DEVICE Liner perforated with very small diameter holes
- DEVICE Liner perforated with somewhat larger diameter holes
- DEVICE Liner-liner
- DEVICE As-prescribed liner
Study Locations (1)
Washington
- VA Puget Sound Health Care System Seattle Division - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 180 participants |
| Start Date | 2022-10-04 |
| Est. Completion | 2026-09 |
| Phase | NA |
What the registry record for NCT07024342 still lists
NCT07024342 is an interventional study that assigns participants to a tested intervention. The registered 180 participants enrollment target is mid-sized for trials with a published cap, above the 130-participant average among 65 other Amputation trials with a reported enrollment target (38% higher).
The record links to 2 conditions, with Amputation appearing as the primary indexed condition, and to 4 interventions - of which Liner perforated with very small diameter holes is the first listed.
NCT07024342 reports a single indexed study location in Washington.
Frequently Asked Questions
What is clinical trial NCT07024342 about?
NCT07024342 is a clinical study titled "Optimizing Prosthetic Prescription to Mitigate the Effects of Perspiration". The specific aim of this research is to compare three clinically available liners, each intended to address problems of residual limb perspiration, with the as-prescribed liner of lower limb prosthesis user and determine their effect on stability, suspension, and comfort.
What is the current status of trial NCT07024342?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 180 participants. The study started on 2022-10-04. Estimated completion is 2026-09.
What conditions does trial NCT07024342 study?
This clinical trial studies the following conditions: Amputation, Prosthesis User.
What interventions are being tested in trial NCT07024342?
The interventions under investigation include: Liner perforated with very small diameter holes (DEVICE), Liner perforated with somewhat larger diameter holes (DEVICE), Liner-liner (DEVICE), As-prescribed liner (DEVICE).
Who is sponsoring clinical trial NCT07024342?
This trial is sponsored by VA Puget Sound Health Care System, which has 16 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07024342 being conducted?
This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Amputation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07024342's enrollment target sits among peer trials
180 7th of 65 higher than 59 of 65 other Amputation trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Amputation trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Evaluation of Myoelectric Implantable Recording Array (MIRA) in Participants With Transradial Amputation
RECRUITING · NA
-
Efficacy and Mechanisms of Virtual Reality Treatment of Phantom Leg Pain.Home-Based Treatment
RECRUITING · NA
-
Hand Transplantation
RECRUITING · NA
-
Target Muscle Re-innervation and Regenerative Peripheral Nerve Interfaces Alone and in Combination for the Treatment of Residual and Phantom Limb Pain in Cancer Patients Who Have Received an Amputation
RECRUITING · NA
-
Can an Array of Micro-electrodes Implanted in a Human Nerve Record Neural Signals and Provide Feedback?
RECRUITING · NA
-
Intuitive Control of a Hybrid Prosthetic Leg During Ambulation
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01558804 · 180 participants
GRoup A StrePtococcus
- NCT02932176 · 180 participants
Machine Learning for Handheld Vascular Studies
- NCT03384563 · 180 participants · Phase 4
Effect of Dexmedetomidine on the Minimum Alveolar Concentration of Sevoflurane
- NCT03423628 · 180 participants · Phase 1
A Study to Assess the Safety and Tolerability of AZD1390 Given With Radiation Therapy in Patients With Brain Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI